The global respiratory device market size is calculated at USD 26,878 million in 2024 and is predicted to reach around USD 69,715 million by 2034, expanding at a CAGR of 10% from 2024 to 2034.
The respiratory devices market is an integral segment of the healthcare industry. Respiratory devices are used to help with breathing and deliver oxygen to the lungs. They can be used by patients at home or in hospitals. Respiratory devices include various machines and equipment to help with breathing such as breathing apparatus, nebulizers, continuous positive airway pressure (CPAP) machine, BiPAP machine, ventilators and face mask among others.
The rising prevalence of respiratory disorders such as asthma, cystic fibrosis, obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD) among others is driving the demand of respiratory devices in the market for providing necessary and efficient patient care. Furthermore, the increase in novel product launches for therapeutic devices, advancements in diagnostics equipment, rising focus of key market players for strengthening and widening their product portfolio and point-of-care diagnostics are the factors boosting the market growth of the respiratory devices segment.
The growing demand for home care therapeutic devices such as nebulizers and the surge in global air pollution leading to higher air quality index (AQI) are the factors creating opportunities for the market players in the imminent years.
Published by Ajit Bansod
Related Reports
